Dan Lindblom
Karolinska University Hospital
55 Papers
908 Citations
Dan Lindblom is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Heart valve & Mitral valve. The author has an hindex of 24, co-authored 55 publications. Previous affiliations of Dan Lindblom include Karolinska Institutet.
Chat about Author
Papers
Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta
TL;DR: Patients with atheromatosis in the ascending aorta had an 8.7% incidence of postoperative stroke, in spite of minor surgical modifications, and the risk depended on the presence, location and extent of the disease.
248
Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin.
Amir Babiker,Olof Andersson,Dan Lindblom,Jan van der Linden,Björn Wiklund,Dieter Lütjohann,Ulf Diczfalusy,Ingemar Björkhem +7 more
TL;DR: The present results suggest that the sterol 27-hydroxylase in the lung is responsible for at least half of the total flux of 27-oxygenated cholesterol metabolites to the liver and that this enzyme system may be of importance for cholesterol homeostasis in the lungs.
119
Mechanical failure of the Björk-Shiley valve. Incidence, clinical presentation, and management.
TL;DR: The time interval between the first symptom of mechanical failure and circulatory collapse was significantly shorter after aortic failure than after mitral failure, and no patient with a fractured aorti prosthesis survived long enough to undergo reoperation.
93
Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease – 12-month follow-up: Angiogenic gene therapy
Nondita Sarkar,Andreas Rück,Göran Källner,Shams Y-Hassan,Pontus Blomberg,Khalid B. Islam,J. van der Linden,Dan Lindblom,Anders T. Nygren,B Lind,Lars-Åke Brodin,Viktor Drvota,Christer Sylvén +12 more
TL;DR: Effects of intramyocardial injection of phVEGF‐A165 as sole therapy in patients with refractory coronary artery disease: 12‐month follow‐up.
79
HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities.
TL;DR: It is suggested that this cardiac syndrome should be regarded as an HLA-B27-associated syndrome, sometimes part of ankylosing spondylitis or Reiter's disease, but just as often presenting without obvious rheumatic disease.
78